Inventor
LEE TAEKYU
US34 patents
⚠️ This page may combine multiple inventors who share the name “LEE TAEKYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VANDERBILT
14 patentsUS10533010B2Jan 14, 2020
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT3 citations71
US10844044B2Nov 24, 2020
WDR5 inhibitors and modulators
UNIV VANDERBILT4 citations69
US10954193B2Mar 23, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations61
US12195472B2Jan 14, 2025
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US11208415B2Dec 28, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US12144816B2Nov 19, 2024
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations59
US11596639B2Mar 7, 2023
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT1 citations59
US10807959B2Oct 20, 2020
WDR5-MLL1 inhibitors and modulators
UNIV VANDERBILT2 citations59
US11999716B2Jun 4, 2024
WDR5 inhibitors and modulators
UNIV VANDERBILT1 citations58
US10005728B2Jun 26, 2018
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations50
US10844032B2Nov 24, 2020
Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations49
US10093640B2Oct 9, 2018
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
UNIV VANDERBILT0 citations49
US12577227B2Mar 17, 2026
WDR5 inhibitors and modulators
UNIV VANDERBILT0 citations46
US9949965B2Apr 24, 2018
Tricyclic indole Mcl-1 inhibitors and uses thereof
UNIV VANDERBILT0 citations40
BRISTOL MYERS SQUIBB PHARMA CO
10 patentsUS7183282B2Feb 27, 2007
Substituted heterocycle fused γ-carbolines
BRISTOL MYERS SQUIBB PHARMA CO145 citations98
US6548493B1Apr 15, 2003
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO179 citations98
USRE39680EJun 5, 2007
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO142 citations97
US7071186B2Jul 4, 2006
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO121 citations97
US6713471B1Mar 30, 2004
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO172 citations97
US6699852B2Mar 2, 2004
Substituted pyridoindoles as serotonin agonists and antagonists
BRISTOL MYERS SQUIBB PHARMA CO130 citations97
US6552017B1Apr 22, 2003
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO208 citations97
USRE39679EJun 5, 2007
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB PHARMA CO129 citations96
US6777406B2Aug 17, 2004
Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists
BRISTOL MYERS SQUIBB PHARMA CO5 citations63
US6638934B2Oct 28, 2003
Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
BRISTOL MYERS SQUIBB CO
9 patentsUS7592454B2Sep 22, 2009
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
BRISTOL MYERS SQUIBB CO62 citations98
US7238690B2Jul 3, 2007
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB CO127 citations98
US7109339B2Sep 19, 2006
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
BRISTOL MYERS SQUIBB CO88 citations98
US7081455B2Jul 25, 2006
Substituted heterocycle fused gamma-carbolines
BRISTOL MYERS SQUIBB CO115 citations98
US6849619B2Feb 1, 2005
Substituted pyridoindoles as serotonin agonists and antagonists
BRISTOL MYERS SQUIBB CO119 citations98
US7858639B2Dec 28, 2010
Bicyclic heterocycles as cannabinoid-1 receptor modulators
BRISTOL MYERS SQUIBB CO30 citations92
US7632837B2Dec 15, 2009
Bicyclic heterocycles as cannabinoid-1 receptor modulators
BRISTOL MYERS SQUIBB CO5 citations62
US7572808B2Aug 11, 2009
Triazolopyridine cannabinoid receptor 1 antagonists
BRISTOL MYERS SQUIBB CO1 citations52
US7795436B2Sep 14, 2010
Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
BRISTOL MYERS SQUIBB CO0 citations42